Topical co ‐administration of zoledronate with recombinant human bone morphogenetic protein-2 can induce and maintain bone formation in the bone marrow environment

Bone morphogenetic proteins (BMPs) induce osteogenesis in various environments. However, when BMPs are used alone in the bone marrow environment, the maintenance of new bone formation is difficult owing to vig...

Source: BMC Musculoskeletal Disorders - January 20, 2021 Category: Orthopaedics Authors: Hideki Ueyama, Yoichi Ohta, Yuuki Imai, Akinobu Suzuki, Ryo Sugama, Yukihide Minoda, Kunio Takaoka and Hiroaki Nakamura Tags: Research article Source Type: research